Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

759718

	registered interest
	date	12/09/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Primary Health Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the effectiveness of the commissioning process for primary medical care services under circumstances where no prospective providers come forward.
	tabling member constituency	Redcar
	tabling member printed	Anna Turley
	uin	10064
	answer	answer is ministerial correction date of answer 09/10/2017 answer text <p>NHS England has a statutory responsibility to ensure that all patients have access to high-quality primary medical care services and enters into contractual arrangements with a range of general practitioner providers to secure those services for the population of England.</p><p> </p><p>The commissioning process to secure services includes, where necessary, approaches to stimulate the provider market. These include engaging with patients and the public, and hosting provider events, working with professional representative groups and other key stakeholders. Options available to commissioners include:</p><p> </p><p>- Procurement through an Alternative Provider Medical Services contract, which allow the widest range of providers to bid for delivery;</p><p> </p><p>- Re-procurement through General Medical Services or Personal Medical Services contracts, which are contracts that can only be held by general practitioners or wider members of the National Health Service family; and</p><p> </p><p>- List dispersal in the case of generally small practices where there is reasonable provision from neighbouring practices.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/10/2017 11:07:42 answering member 4067 label Biography information for Steve Brine
	tabling member	4449 label Biography information for Anna Turley

759719

	registered interest
	date	12/09/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Centres: Marske by the Sea
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will make an assessment of the effect of the closure of Marske Medical Centre on the costs of travel for patients who must travel further to access GP services.
	tabling member constituency	Redcar
	tabling member printed	Anna Turley
	uin	10065
	answer	answer is ministerial correction date of answer 09/10/2017 answer text <p>South Tees Clinical Commissioning Group (CCG) made the decision to close Marske Medical Practice after four unsuccessful attempts find a new provider for the service. The practice therefore closed on 30 June 2017. The CCG continues to support patients following the closure and the great majority of them have re-registered with nearby practices, which have increased staffing levels to manage demand.</p><p> </p><p>At this stage the CCG has not assessed travel costs for patients who may need to travel further to see their general practitioner.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/10/2017 12:39:29 answering member 4067 label Biography information for Steve Brine
	tabling member	4449 label Biography information for Anna Turley

786402

	registered interest
	date	07/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Thyroid Gland: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the effect of the non-availability of Lithyronine on the NHS on patients who have previously being prescribed that drug.
	tabling member constituency	Redcar
	tabling member printed	Anna Turley
	uin	112033
	answer	answer is ministerial correction date of answer 17/11/2017 answer text <p>NHS England’s consultation on draft guidance for clinical commissioning groups on a range of items that should not routinely be prescribed in primary care ended on 21 October.</p><p> </p><p>We would not want to pre-empt any outcome following NHS England’s analysis of the responses it has received. However, we are assured that as part of issuing the final guidance, careful consideration will be given by NHS England to the responses to the consultation, both to ensure that particular groups of people are not disproportionately affected and that principles of best practice on clinical prescribing are adhered to – including guidance on the usage of liothyronine.</p><p> </p><p>Further information can be found at the following link:</p><p><a href="https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed/" target="_blank">https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed/</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/11/2017 11:47:40 answering member 4067 label Biography information for Steve Brine
	tabling member	4449 label Biography information for Anna Turley

786404

	registered interest
	date	07/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Thyroid Gland: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure Lithyronine sold by third parties meets legal requirements and its safe sale for patients to use.
	tabling member constituency	Redcar
	tabling member printed	Anna Turley
	uin	112034
	answer	answer is ministerial correction date of answer 17/11/2017 answer text <p>Liothyronine is a licensed medicine used for the treatment of hypothyroidism, an underactive thyroid gland. Licensed medicines must meet standards of safety, quality and efficacy. Each batch of medicine must be tested before release for sale. The manufacturer, importer and distributors must also be licensed. Medicines and Healthcare products Regulatory Agency (MHRA), the United Kingdom competent authority for medicines, license medicines, their manufacture, importation and distribution and conduct inspections of sites of operation for compliance with good practice standards.</p><p> </p><p>Prescribers may, on their own personal responsibility, also prescribe an unlicensed medicine to meet the special clinical needs of their individual patient where those needs cannot be met by an available licensed medicine. Manufacturers, importers and distributors of unlicensed medicine are also licensed and inspected by MHRA. Importers must notify MHRA of the intention to import an unlicensed medicine. These notifications are assessed by MHRA for known safety or quality issues and objections to import may be raised if prohibitive issues are identified. Unlicensed Liothyronine has been manufactured and imported for UK patients.</p><p> </p><p>A prescriber or patient that suspects that their medicine is defective or is causing a side effect may report this to MHRA through the Yellow Card Scheme for reporting suspected Adverse Drug Reactions from across the whole UK and includes all medicines.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/11/2017 11:43:12 answering member 4067 label Biography information for Steve Brine
	tabling member	4449 label Biography information for Anna Turley

786405

	registered interest
	date	07/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Medicine: Internet
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment his Department has made of the effect of the UK leaving the EU on the price of medication sold online by third parties.
	tabling member constituency	Redcar
	tabling member printed	Anna Turley
	uin	112035
	answer	answer is ministerial correction date of answer 17/11/2017 answer text <p>The Government is assessing the potential implications of the United Kingdom’s withdrawal from the European Union across the medicines supply chain. While we cannot pre-judge the outcome of the negotiations, our aim is to ensure that patients in the UK and across the EU will continue to be able to access the best and most innovative medicines and be assured that their safety is protected through the strongest regulatory framework and sharing of data.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/11/2017 11:45:55 answering member 4067 label Biography information for Steve Brine
	tabling member	4449 label Biography information for Anna Turley

786220

	registered interest
	date	07/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Smoking
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will bring forward legislative proposals to prohibit smoking on the grounds of hospitals, health centres and other NHS buildings in England.
	tabling member constituency	Redcar
	tabling member printed	Anna Turley
	uin	112062
	answer	answer is ministerial correction date of answer 13/11/2017 answer text <p>The Department supports the implementation of smokefree policies across all hospitals in England. The Government published the Tobacco Control Plan on 18 July 2017, which outlines the ambition of achieving a smokefree National Health Service estate by 2020. There are no plans for new legislation.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 13/11/2017 16:53:49 answering member 4067 label Biography information for Steve Brine
	tabling member	4449 label Biography information for Anna Turley

806680

	registered interest
	date	14/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Arthritis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate his Department has made of the number of patients receiving treatment for arthritis in (a) South Tees NHS Trust, (b) the North East and (c) England.
	tabling member constituency	Redcar
	tabling member printed	Anna Turley
	uin	119756
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>No specific estimate has been made. The majority of patients receiving treatment for rheumatoid arthritis are managed in outpatient settings where data collection is not mandated.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:23:31 answering member 4067 label Biography information for Steve Brine
	tabling member	4449 label Biography information for Anna Turley

806681

	registered interest
	date	14/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	General Practitioners
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate his Department has made of the number of full-time practising GPs in (a) South Tees NHS Trust, (b) the North East and (c) England for each of the last five years for which figures are available.
	tabling member constituency	Redcar
	tabling member printed	Anna Turley
	uin	119757
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>The requested information is shown in the table below. The table shows data for general practitioner (GP) full-time equivalent figures for NHS South Tees Clinical Commissioning Group (CCG), NHS England North (Cumbria and North East) and England, for each of the years in question. Prior to 2015, the locum headcounts were not recorded.</p><table><tbody><tr><td rowspan="2"><p>Year</p></td><td colspan="3"><p>All GPs Full-Time Equivalent</p></td><td colspan="3"><p>All GPs (Excluding Registrars, Retainers and Locums) Full-Time Equivalent</p></td></tr><tr><td><p>England</p></td><td><p>NHS England North (Cumbria and North East)</p></td><td><p>NHS South Tees CCG</p></td><td><p>England</p></td><td><p>NHS England North (Cumbria and North East)</p></td><td><p>NHS South Tees CCG</p></td></tr><tr><td><p>March 2017</p></td><td><p>33,921</p></td><td><p>1,679</p></td><td><p>156</p></td><td><p>28,092</p></td><td><p>1,544</p></td><td><p>145</p></td></tr><tr><td><p>September 2016</p></td><td><p>34,495</p></td><td><p>1,837</p></td><td><p>154</p></td><td><p>28,458</p></td><td><p>1,724</p></td><td><p>142</p></td></tr><tr><td><p>September 2015</p></td><td><p>34,592</p></td><td><p>1,910</p></td><td><p>165</p></td><td><p>29,229</p></td><td><p>1,774</p></td><td><p>150</p></td></tr><tr><td><p>September 2014</p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p>32,628</p></td><td><p>2,160</p></td><td><p>180</p></td></tr><tr><td><p>September 2013</p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p>32,075</p></td><td><p>2,143</p></td><td><p>189</p></td></tr></tbody></table><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:58:10 answering member 4067 label Biography information for Steve Brine
	tabling member	4449 label Biography information for Anna Turley

1050590

	registered interest
	date	29/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pancreatic Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the outcomes of pancreatic cancer diagnoses in line with the NHS England 2015 cancer strategy.
	tabling member constituency	Redcar
	tabling member printed	Anna Turley
	uin	214126
	answer	answer is ministerial correction date of answer 04/02/2019 answer text <p>The 2015 cancer strategy set ambitions for higher survival and improved patient experience and quality of life for all cancer patients, including pancreatic cancer patients. The NHS Long Term Plan takes forward those ambitions, stating that by 2028 three in four cancers will be diagnosed at an early stage and 55,000 more people will survive their cancer for five years or more.</p><p> </p><p>Over the last two years, NHS England have allocated over £200 million funding through their Cancer Alliances for earlier diagnosis and personalised care. In addition, £130 million funding has been invested in over 80 new or replacement linear accelerators in the modernisation of radiotherapy services.</p><p> </p><p>NHS England will shortly be introducing a Faster Diagnostic Standard of 28 days for all cancer patients, including those with pancreatic cancer, which when taken together with the 62-day referral to treatment standard, will mean that all patients should expect to start their treatment within 34 days of diagnosis. This is a maximum, and trusts should continue to treat patients more quickly particularly where there is a strong clinical need.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 04/02/2019 18:03:12 answering member 4067 label Biography information for Steve Brine
	tabling member	4449 label Biography information for Anna Turley

1058880

	registered interest
	date	11/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lymphoedema: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the accessibility of services for treating lymphoedema in (a) the North East and (b) England.
	tabling member constituency	Redcar
	tabling member printed	Anna Turley
	uin	219492
	answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>No specific assessment of the availability of lymphoedema services has been made. The commissioning of services for the treatment and care of lymphoedema patients is a local matter.</p><p>People with lymphoedema can usually be managed through routine access to primary or secondary care services. A range of guidance is available for the diagnosis, treatment and care for people with lymphoedema. This includes an international consensus document on best practice and guidance from the National Institute for Health and Care Excellence.</p><p>Further information can be found at the following links:</p><p><a href="http://www.nice.org.uk/guidance/ipg588" target="_blank">www.nice.org.uk/guidance/ipg588</a></p><p><a href="http://www.woundsinternational.com/resources/details/bioimpedance-analysis-in-the-assessment-of-lymphoedema-diagnosis-and-management" target="_blank">www.woundsinternational.com/resources/details/bioimpedance-analysis-in-the-assessment-of-lymphoedema-diagnosis-and-management</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 219493 question first answered 14/02/2019 17:33:46 answering member 4067 label Biography information for Steve Brine
	tabling member	4449 label Biography information for Anna Turley